nach oben

Erschienen in:

02.06.2020 | COVID-19 | Editorial Zur Zeit gratis

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

verfasst von: Laura M. Mongioì, Federica Barbagallo, Rosita A. Condorelli, Rossella Cannarella, Antonio Aversa, Sandro La Vignera, Aldo E. Calogero

Erschienen in: Endocrine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is centralizing the interest of the scientific world. In the next months, long-term consequences on the endocrine system may arise following COVID-19. In this article, we hypothesized the effects of SARS-CoV-2 taking into account what learned from the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS in 2003.

F. Wu, S. Zhao, B. Yu, Y.M. Chen, W. Wang, Z.G. Song, Y. Hu, Z.W. Tao, J.H. Tian, Y.Y. Pei, M.L. Yuan, Y.L. Zhang, F.H. Dai, Y. Liu, Q.M. Wang, J.J. Zheng, L. Xu, E.C. Holmes, Y.Z. Zhang, A new coronavirus associated with human respiratory disease in China. Nature 579(7798), 265–269 (2020). https://doi.org/10.1038/s41586-020-2008-3.CrossRefPubMedPubMedCentral

J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, V.C. Cheng, K.H. Chan, D.N. Tsang, R.W. Yung, T.K. Ng, K.Y. Yuen,SARS study group, Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361(9366), 1319–1325 (2003).CrossRefPubMedPubMedCentral

Y. Ding, L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, S. Jiang, Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203(2), 622–630 (2004).CrossRefPubMedPubMedCentral

M. Xie, Q. Chen, Insight into 2019 novel coronavirus—an updated intrim review and lessons from SARS-CoV and MERS-CoV. Int. J. Infect. Dis. (2020). S1201-9712(20)30204-6. https://doi.org/10.1016/j.ijid.2020.03.071.

J.W. Chan, C.K. Ng, Y.H. Chan, T.Y. Mok, S. Lee, S.Y. Chu, W.L. Law, M.P. Lee, P.C. Li, Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 58(8), 686–689 (2003).CrossRefPubMedPubMedCentral

J.K. Yang, Y. Feng, M.Y. Yuan, S.Y. Yuan, H.J. Fu, B.Y. Wu, G.Z. Sun, G.R. Yang, X.L. Zhang, L. Wang, X. Xu, X.P. Xu, J.C. Chan, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet. Med. 23(6), 623–628 (2006).CrossRefPubMed

M. Puig-Domingo, M. Marazuela, A. Giustina, COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1), 2–5 (2020). https://doi.org/10.1007/s12020-020-02294-5.CrossRefPubMedPubMedCentral

J.K. Yang, S.S. Lin, X.J. Ji, L.M. Guo, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 47(3), 193–199 (2010). https://doi.org/10.1007/s00592-009-0109-4.CrossRefPubMed

Y. Ding, L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, S. Jiang, Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 203(2), 622–630 (2004).CrossRefPubMedPubMedCentral

10.

S. La Vignera, R. Cannarella, R.A. Condorelli, F. Torre, A. Aversa, A.E. Calogero, Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int. J. Mol. Sci. 21(8), E2948 (2020). https://doi.org/10.3390/ijms21082948.

11.

N. Sattar, I.B. McInnes, J.J.V. McMurray, Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. (2020). https://doi.org/10.1161/CIRCULATIONAHA.120.047659.

12.

J. Lighter, M. Phillips, S. Hochman, S. Sterling, D. Johnson, F. Francois, A. Stachel, Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin. Infect. Dis. ciaa415 (2020). https://doi.org/10.1093/cid/ciaa415.

13.

F.P. de Heredia, S. Gómez-Martínez, A. Marcos, Obesity, inflammation and the immune system. Proc. Nutr. Soc. 71(2), 332–338 (2012). https://doi.org/10.1017/S0029665112000092.CrossRefPubMed

14.

W.D. Green, M.A. Beck, Obesity impairs the adaptive immune response to influenza virus. Ann. Am. Thorac. Soc. 14(Supplement_5), S406–S409 (2017). https://doi.org/10.1513/AnnalsATS.201706-447AW.CrossRefPubMedPubMedCentral

15.

R. Wheatland, Molecular mimicry of ACTH in SARS—implications for corticosteroid treatment and prophylaxis. Med. Hypotheses. 63(5), 855–862 (2004).CrossRefPubMedPubMedCentral

16.

M.K. Leow, D.S. Kwek, A.W. Ng, K.C. Ong, G.J. Kaw, L.S. Lee, Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin. Endocrinol. 63(2), 197–202 (2005).CrossRef

17.

C. Scaroni, M. Armigliato, S. Cannavò, COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? J. Endocrinol. Investig. (2020). https://doi.org/10.1007/s40618-020-01253-1.

18.

L. Wei, S. Sun, C.H. Xu, J. Zhang, Y. Xu, H. Zhu, S.C. Peh, C. Korteweg, M.A. McNutt, J. Gu, Pathology of the thyroid in severe acute respiratory syndrome. Hum. Pathol. 38(1), 95–102 (2007).CrossRefPubMed

19.

L. Wei, S. Sun, J. Zhang, H. Zhu, Y. Xu, Q. Ma, M.A. McNutt, C. Korteweg, J. Gu, Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem. Cell Biol. 88(4), 723–730 (2010). https://doi.org/10.1139/O10-022.CrossRefPubMed

20.

J. Lyons-Weiler, Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J. Transl. Autoimmun. 100051 (2020). https://doi.org/10.1016/j.jtauto.2020.100051.

21.

J. Xu, L. Qi, X. Chi, J. Yang, X. Wei, E. Gong, S. Peh, J. Gu, Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol. Reprod. 74(2), 410–416 (2006).CrossRefPubMed

Titel: Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model
verfasst von: Laura M. Mongioì
Federica Barbagallo
Rosita A. Condorelli
Rossella Cannarella
Antonio Aversa
Sandro La Vignera
Aldo E. Calogero
Publikationsdatum: 02.06.2020
Verlag: Springer US
Schlagwort: COVID-19
Erschienen in: Endocrine / Ausgabe 3/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02349-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study

Approved LXR agonists exert unspecific effects on pancreatic β-cell function

Thyroid disease in the time of COVID-19

Glucagon-like peptide-2 analog and inflammatory state in obese mice

The oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin